Let’s even make it 30 days earlier for ezetimibe generics

Although a hyperlipidemia treatment substance, ‘ezetimibe,’ is about to be expired in patent, a series of domestic companies have filed trials to avoid the patent. The phenomenon is interpreted as their will to launch products even a month or two months earlier.

The ezetimibe’s patent will be expired on the coming 29^th of April. Thus, generics for the ezebimibe-simvastatin complex(brand name: ...